Nov. 17, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) announced today that it has …
Nov 13 (Reuters) - Anthera Pharmaceuticals Inc ::Anthera Pharmaceuticals Inc files for resale of up to 28.6 million shares of co's common stock by the selling stockholders‍ .
Pizza chain Papa John’s reported disappointing quarterly earnings, and then execs threw gas on the fire by blaming NFL leaders for the season’s “significant decline” in TV ratings. Shares closed at $62.26, down 9%, partly due to doughy …
Shares of Anthera Pharmaceuticals Inc. plummeted 84% in premarket trade Monday, after the biopharmaceutical company said it would suspend further development of Sollpura after a phase 3 study of exocrine ...
Citigroup recently reiterated its buy rating and $15 price target on Anthera's stock. Anthera Pharmaceuticals (NASDAQ:ANTH) is a tiny biotech that trades primarily on hope at this point. The company's stock price moved …
ANTH SHIP DIRECTLY TO THE CONSUMER ... THAI UNION SAYS THE PRODUCT WILL NOT PLACE STRAIN ON THE OVERALL STOCK SINCE IT IS MADE HIM …
Anthera Pharmaceuticals, Inc. ANTH announced disappointing top-line data from a phase ... Anthera’s year-to-date share price movement shows that the stock has underperformed the Zacks classified Medical - Biomedical and Genetics …
April 28, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-8 reverse stock split …